Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge

Journal of Psychopharmacology

Volumn 24, Issue 10, 2010, Pages 1551-1560

  Painsipp, Evelin ^a   Herzog, Herbert ^b   Holzer, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

anxiety related behaviour; bacterial lipopolysaccharide (endotoxin); depression like behaviour; neuropeptide Y Y2 receptors; neuropeptide Y Y4 receptors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; FEMALE; IMMUNE FUNCTION TEST; KNOCKOUT MOUSE; LONG TERM DEPRESSION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; EXPLORATORY BEHAVIOR; FEMALE; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SWIMMING; TIME FACTORS;

EID: 77957978176     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109348171     Document Type: Article

References (60)

1. Anisman H., Merali Z., Poulter MO, Hayley S. (2005) Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Design 11: 963-972.
2. Bluthé RM, Michaud B., Poli V., Dantzer R. (2000) Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav 70: 367-373.
3. Campbell RE, Smith MS, Allen SE, Grayson BE, Ffrench-Mullen JM, Grove KL (2003) Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23: 1487-1497.
4. Capuron L., Ravaud A., Dantzer R. (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon α-2b therapy. J Clin Oncol 18: 2143-2151.
5. Capuron L., Ravaud A., Gualde N., et al. (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26: 797-808.
6. Carvajal C., Dumont Y., Herzog H., Quirion R. (2006) Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice. J Mol Neurosci 28: 239-245.
7. Cryan JF, Mombereau C. (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatr 9: 326-357.
8. Cryan JF, Valentino RJ, Lucki I. (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547-569.
9. Dantzer R. (2006) Cytokine, sickness behavior, and depression. Neurol Clin 24: 441-460.
10. Detke MJ, Rickels M., Lucki I. (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin) 21: 66-72.
11. Dunn AJ, Swiergiel AH (2005) Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 81: 688-693.
12. Dunn AJ, Swiergiel AH, De Beaurepaire R. (2005) Cytokines as mediators of depression: what can we learn from animal studies ? Neurosci Biobehav Rev 29: 891-909.
13. Fetissov SO, Kopp J., Hökfelt T. (2004) Distribution of NPY receptors in the hypothalamus. Neuropeptides 38: 175-188.
14. Fishkin RJ, Winslow JT (1997) Endotoxin-induced reduction of social investigation by mice: interaction with amphetamine and anti-inflammatory drugs. Psychopharmacology 132: 335-341.
15. Frenois F., Moreau M., O'Connor J., et al. (2007) Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516-531.
16. Goehler LE, Gaykema RPA, Hansen MK, Anderson K., Maier SF, Watkins LR (2000) Vagal immune-to-brain communication: a visceral chemosensory pathway. Autonomic Neurosci 85: 49-59.
17. Goehler LE, Lyte M., Gaykema RP (2007) Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun 21: 721-726.
18. Gorman JM (2006) Gender differences in depression and response to psychotropic medication. Gender Med 3: 93-109.
19. Gustafson EL, Smith KE, Durkin MM, et al. (1997) Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol Brain Res 46: 223-235.
20. Harbuz MS, Chover-Gonzalez A., Gibert-Rahola J., Jessop DS (2002) Protective effect of prior acute immune challenge, but not foot-shock, on inflammation in the rat. Brain Behav Immun 16: 439-449.
21. Heilig M. (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224.
22. Jain NK, Kulkarni SK, Singh A. (2001) Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Method Find Exp Clin Pharmacol 23: 441-444.
23. Karl T., Herzog H. (2007) Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides 28: 326-333.
24. Kask A., Harro J., Von Hörsten S., Redrobe JP, Dumont Y., Quirion R. (2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26: 259-283.
25. Kirk RE (1995) Experimental Design. Procedures for the Behavioral Sciences, 3 rd edn. Pacific Grove, CA: Brooks/Cole.
26. Konsman JP, Dantzer R. (2001) How the immune and nervous systems interact during disease-associated anorexia. Nutrition 17: 664-668.
27. Konsman JP, Parnet P., Dantzer R. (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25: 154-159.
28. Lacosta S., Merali Z., Anisman H. (1999) Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 818: 291-303.
29. Lin S., Boey D., Herzog H. (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189-200.
30. McCarthy HD, Dryden S., Williams G. (1995) Interleukin-1β-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y. Am J Physiol 269: E852 - E857.
31. McMahon CD, Buxton DF, Elsasser TH, et al. (1999) Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J Endocrinol 161: 333-339.
32. Maes M. (2008) The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol Lett 29: 287-291.
33. Michel MC, Beck-Sickinger A., Cox H., et al. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143-150.
34. Mormede C., Palin K., Kelley KW, Castanon N., Dantzer R. (2004) Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. Brain Behav Immun 18: 186-200.
35. Painsipp E., Herzog H., Holzer P. (2008 a) Implication of neuropeptideY Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice. Neuropharmacology 55: 117-126.
36. Painsipp E., Sperk G., Herzog H., Holzer P. (2009) Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice. J Psychopharmacol (in press).
37. Painsipp E., Wultsch T., Edelsbrunner ME, et al. (2008 b) Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7: 532-542.
38. Painsipp E., Wultsch T., Shahbazian A., et al. (2007) Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150: 522-536.
39. Palanza P. (2001) Animal models of anxiety and depression: how are females different ? Neurosci Biobehav Rev 25: 219-233.
40. Parker RM, Herzog H. (1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11: 1431-1448.
41. Redrobe JP, Carvajal C., Kask A., Dumont Y., Quirion R. (2004) Neuropeptide Y and its receptor subtypes in the central nervous system: emphasis on their role in animal models of psychiatric disorders. In: Michel MC (ed.) Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology Vol. 162, Berlin: Springer, 101-136.
42. Redrobe JP, Dumont Y., Herzog H., Quirion R. (2003) Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 141: 251-255.
43. Reichenberg A., Yirmiya R., Schuld A., et al. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiat 58: 445-452.
44. Richards LJ, Chover-Gonzalez A., Harbuz MS, Jessop DS (2006) Protective effects of endotoxin in a rat model of chronic inflammation are accompanied by suppressed secretion of pro-inflammatory cytokines and biphasic alteration in hypothalamo-pituitary-adrenal axis activity. J Neuroendocrinol 18: 875-882.
45. Romanovsky AA, Almeida MC, Aronoff DM, et al. (2005) Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 10: 2193-2216.
46. Sainsbury A., Schwarzer C., Couzens M., et al. (2002 a) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. P Natl Acad Sci USA 99: 8938-8943.
47. Sainsbury A., Schwarzer C., Couzens M., et al. (2002 b) Y4 receptor knockout rescues fertility in ob/ob mice. Gene Dev 16: 1077-1088.
48. Simonds VM, Whiffen VE (2003) Are gender differences in depression explained by gender differences in co-morbid anxiety ? J Affect Disorders 77: 197-202.
49. Sonti G., Ilyin SE, Plata-Salaman CR (1996) Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides 17: 517-520.
50. Stanic D., Brumovsky P., Fetissov S., Shuster S., Herzog H., Hökfelt T. (2006) Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol 499: 357-390.
51. Swiergiel AH, Dunn AJ (2007) Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Neurosci Biobehav Rev 86: 651-659.
52. Tasan RO, Lin S., Hetzenauer A., Singewald N., Herzog H., Sperk G (2009) Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158: 1717-1730.
53. Tonelli LH, Holmes A., Postolache TT (2008) Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology 33: 1038-1048.
54. Tschenett A., Singewald N., Carli M., et al. (2003) Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148.
55. Vallès A., Martí O., Armario A. (2003) Long-term effects of a single exposure to immobilization stress on the hypothalamic-pituitary- adrenal axis: transcriptional evidence for a progressive desensitization process. Eur J Neurosci 18: 1353-1361. (Pubitemid 37215091)
56. Vallès A., Martí O., Armario A. (2005) Mapping the areas sensitive to long-term endotoxin tolerance in the rat brain: a c-fos mRNA study. J Neurochem 93: 1177-1188.
57. Vallès A., Martí O., Harbuz MS, Armario A. (2002) A single lipopolysaccharide administration is sufficient to induce a long-term desensitization of the hypothalamic-pituitary-adrenal axis. Neuroscience 112: 383-389.
58. Whitcomb DC, Puccio AM, Vigna SR, Taylor IL, Hoffman GE (1997) Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res 760: 137-149.
59. Zhang YH, Lu J., Elmquist JK, Saper CB (2000) Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord. J Neurosci 20: 6578-6586.
60. Zhou Z., Zhu G., Hariri AR, et al. (2008) Genetic variation in human NPY expression affects stress response and emotion. Nature 452: 997-1001.